Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Financial statements and analysis
Showing the last 2 fiscal years: 2024 to 2025
Chart shows data from left to right: oldest period → newest period
X-axis shows fiscal years with their term end dates and filing dates
Period names from company filings, with term end dates and filing dates
Income Statement (USD) Term End Date Filing Date | 2025 Dec 31, 2025 Mar 19, 2026 | 2024 Dec 31, 2024 Mar 19, 2026 |
|---|
Total Revenue | 53.57M 7.6% | 49.79M |
Cost of Revenue | - | - |
Gross Profit | - | - |
Gross Margin % | - | - |
Research & Development | - | - |
General & Administrative | - | - |
Selling & Marketing | - | - |
SG&A Expenses | - | - |
Other Operating Expenses | - | - |
Total Operating Expenses | 120.58M 102.5% | 59.56M |
Cost and Expenses | - | - |
Operating Income | - | - |
Operating Margin % | - | - |
EBITDA | - | - |
EBITDA Margin % | - | - |
Interest Expense | 7.80M 11.4% | 7.00M |
Interest Income | - | - |
Other Income (Expense) | - | - |
Pre-Tax Income | -58.46M 497.7% | -9.78M |
Pre-Tax Margin % | -109.00% 445.0% | -20.00% |
Tax Provision | - | - |
Net Income | -60.85M 485.8% | -10.39M |
Net Margin % | -114.00% 442.9% | -21.00% |
Basic EPS | -7.08 316.5% | -1.70 |
Diluted EPS | -7.08 316.5% | -1.70 |
Basic Shares Outstanding | 8.60M 40.6% | 6.11M |
Diluted Shares Outstanding | 8.60M 40.6% | 6.11M |